Election of Director to hold office for the ensuing three years and until their successors have been duly elected and qualified: Frederick M. Hudson
Election of Director to hold office for the ensuing three years and until their successors have been duly elected and qualified: Charles W. Newhall, III
To approve, on a non-binding basis, the compensation paid to our named executive officers.
To ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.
To consider and act upon a proposal to amend the Supernus Pharmaceuticals, Inc. 2021 Equity Incentive Plan to increase the number of shares available under the plan.